NCT04788147View on ClinicalTrials.gov

Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
CancerTumor, SolidCancer, LungCancer, BoneMetastasis to LungMetastasis to Bone
Interventions
DEVICE

RMRS IDE Device

Participants will be injected with FDG at the studied dose and will undergo imaging sessions using the RMRS IDE device and a third-party Positron Emission Tomography (PET)/CT imaging device.

Trial Locations (2)

75390

UT Southwestern, Dallas

94305

Stanford University, Stanford

Sponsors

Lead Sponsor

RefleXion Medical
All Listed Sponsors
lead

RefleXion Medical

INDUSTRY